Please wait while the formulary information is being retrieved.
URINARY PAIN RELIEF (PHENAZOPYRIDINE HCL)
- Dysuria
- Urinary tract irritation
95 mg tablet
- Dosage information is not available
97.5 mg tablet
- Dosage information is not available
95 mg tablet
- Dosage information is not available
97.5 mg tablet
- Dosage information is not available
99.5 mg tablet
- Dosage information is not available
- None
Contraindicated
- None
Severe
Moderate
- None
- Acute hepatitis
- Glomerulonephritis
- Glucose-6-phosphate dehydrogenase (g6Pd) deficiency
- Hemolytic anemia from PK and g6PD deficiencies
- Kidney disease with reduction in GFR
- Uremia
Contraindicated
- None
Severe
Moderate
- None
URINARY PAIN RELIEF (PHENAZOPYRIDINE HCL)
- Dysuria
- Urinary tract irritation
- None
- None
More Frequent
Severe
Less Severe
- None
- Abdominal pain with cramps
- Dizziness
- Headache disorder
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Allergic dermatitis
- Drug-induced hepatitis
- Glucose-6-phosphate dehydrogenase deficiency anemia
- Hemolytic anemia
- Jaundice
- Kidney disease with reduction in GFR
- Methemoglobinemia
- Non-infective meningitis
- Renal failure
- Skin rash
Less Severe
- None
Contraindicated
None
Severe Precaution
Phenazopyridine
Not recommended age less than 12 years per manufacturer.
- 1 Day – 12 Years
- Not recommended age less than 12 years per manufacturer.
Management or Monitoring Precaution
None
Phenazopyridine Hydrochloride
- Severity Level:
B
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Phenazopyridine
Insufficient data available;Should not be used if infant has g6Pd deficiency
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available;Should not be used if infant has g6Pd deficiency |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
Phenazopyridine
Renal-Increased risk of accumulation and toxicity.
| Organ / System | HEP | REN | CARD | ENDO | NEURO / PSYCH | PULM |
| Increased Risk / Adverse Effects | Y | N | N | N | N | N |
BEERS: N HEDIS: N STOPP: N
No Known Risk
None
- None
| Dysuria | |
| R30.0 | Dysuria |
| 0-9 | A-Z |
|---|---|
| R30.0 | Dysuria |
Formulary Reference Tool